secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0000950170-24-133817
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 5.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences to combine with Roosevelt Resources in all-stock reverse merger; Roosevelt owners to get ~90%
--------------------------------------------------------------------------------

- Arcadia to issue shares for all Roosevelt equity; current Arcadia shareholders will own ~10% of combined company.
- Roosevelt's primary asset: 16,208-acre CCUS oil and gas project in Texas Permian Basin.
- Combined company management: Elliott Roosevelt Jr. as CEO, Jimmy Hawkins as President, Jerrel Branson as CFO.
- Name change to Roosevelt Resources, Inc.; closing expected Q1 2025, subject to shareholder and regulatory approvals.
- Arcadia had conducted strategic review since July 2023; deal advised by Lake Street Capital and Roth Capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024133817/0000950170-24-133817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024133817/rkda-20241204.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-133817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer